Further, in a recent, small study of JIA patients by Levalampi and colleagues, treatment with infliximab resulted in reductions in levels of C-reactive protein (CRP), adhesion molecules (ICAM-1, E -selectin) and myeloperoxidase [14]. This evidence concerns the gene SELE and juvenile idiopathic arthritis.